A blog about Global Health. An open space for discussing equitable access to health for everyone, everywhere.

Research team finds genetic engineered Lyme bacterial proteins could offer long-standing protection against infection while requiring fewer vaccinations.

The outer surface protein CspZ is a potential vaccine candidate of Borrelia burgdorferi for Lyme disease prevention. Here, using structure-based design, the authors generate a mutant CspZ protein with...